| Title |
Evidence for decline in the incidence of cystic fibrosis: a 35-year observational study in Brittany, France
|
|---|---|
| Published in |
Orphanet Journal of Rare Diseases, March 2012
|
| DOI | 10.1186/1750-1172-7-14 |
| Pubmed ID | |
| Authors |
Virginie Scotet, Ingrid Duguépéroux, Philippe Saliou, Gilles Rault, Michel Roussey, Marie-Pierre Audrézet, Claude Férec |
| Abstract |
Cystic fibrosis (CF) is an autosomal recessive disorder whose incidence has long been estimated as 1/2500 live births in Caucasians. Expanding implementation of newborn screening (NBS) programs now allows a better monitoring of the disease incidence, what is essential to make reliable predictions for disease management. This study assessed time trends in the birth incidence of CF over a long period (35 years: 1975-2009) in an area where CF is frequent (Brittany, France) and where NBS has been implemented for more than 20 years. |
X Demographics
The data shown below were collected from the profiles of 4 X users who shared this research output. Click here to find out more about how the information was compiled.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| United Kingdom | 1 | 25% |
| Ireland | 1 | 25% |
| Colombia | 1 | 25% |
| Unknown | 1 | 25% |
Demographic breakdown
| Type | Count | As % |
|---|---|---|
| Members of the public | 4 | 100% |
Mendeley readers
The data shown below were compiled from readership statistics for 187 Mendeley readers of this research output. Click here to see the associated Mendeley record.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| United States | 1 | <1% |
| Brazil | 1 | <1% |
| Unknown | 185 | 99% |
Demographic breakdown
| Readers by professional status | Count | As % |
|---|---|---|
| Researcher | 22 | 12% |
| Student > Bachelor | 19 | 10% |
| Student > Master | 18 | 10% |
| Student > Ph. D. Student | 17 | 9% |
| Other | 16 | 9% |
| Other | 45 | 24% |
| Unknown | 50 | 27% |
| Readers by discipline | Count | As % |
|---|---|---|
| Medicine and Dentistry | 53 | 28% |
| Agricultural and Biological Sciences | 21 | 11% |
| Biochemistry, Genetics and Molecular Biology | 20 | 11% |
| Nursing and Health Professions | 9 | 5% |
| Pharmacology, Toxicology and Pharmaceutical Science | 6 | 3% |
| Other | 25 | 13% |
| Unknown | 53 | 28% |
Attention Score in Context
This research output has an Altmetric Attention Score of 6. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 18 February 2020.
All research outputs
#5,524,625
of 25,654,806 outputs
Outputs from Orphanet Journal of Rare Diseases
#782
of 3,163 outputs
Outputs of similar age
#34,206
of 168,776 outputs
Outputs of similar age from Orphanet Journal of Rare Diseases
#3
of 13 outputs
Altmetric has tracked 25,654,806 research outputs across all sources so far. Compared to these this one has done well and is in the 75th percentile: it's in the top 25% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 3,163 research outputs from this source. They typically receive more attention than average, with a mean Attention Score of 8.2. This one has gotten more attention than average, scoring higher than 74% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 168,776 tracked outputs that were published within six weeks on either side of this one in any source. This one has done well, scoring higher than 76% of its contemporaries.
We're also able to compare this research output to 13 others from the same source and published within six weeks on either side of this one. This one has done well, scoring higher than 76% of its contemporaries.